Metropolitan Life Insurance Company (MetLife)’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,762
Closed -$913K 2588
2021
Q4
$913K Sell
6,762
-133
-2% -$18.5K 0.01% 1030
2021
Q3
$973K Sell
6,895
-398
-5% -$53.5K 0.01% 977
2021
Q2
$934K Sell
7,293
-1,911
-21% -$225K 0.01% 1063
2021
Q1
$1.18M Buy
9,204
+262
+3% +$48.4K 0.02% 834
2020
Q4
$1.61M Sell
8,942
-198
-2% -$44K 0.02% 587
2020
Q3
$2.01M Sell
9,140
-444
-5% -$99.1K 0.03% 410
2020
Q2
$2.14M Sell
9,584
-1,231
-11% -$193K 0.04% 379
2020
Q1
$1.06M Sell
10,815
-575
-5% -$46.5K 0.02% 654
2019
Q4
$855K Sell
11,390
-378
-3% -$24.4K 0.01% 987
2019
Q3
$722K Buy
11,768
+938
+9% +$56.4K 0.01% 1058
2019
Q2
$642K Hold
10,830
0.01% 1145
2019
Q1
$709K Hold
10,830
0.01% 1089
2018
Q4
$529K Buy
10,830
+144
+1% +$8.6K 0.01% 1161
2018
Q3
$696K Hold
10,686
0.01% 1145
2018
Q2
$711K Buy
10,686
+1,466
+16% +$88.6K 0.01% 1097
2018
Q1
$478K Hold
9,220
0.01% 1308
2017
Q4
$400K Sell
9,220
-10,387
-53% -$425K 0.01% 1429
2017
Q3
$860K Hold
19,607
0.01% 1347
2017
Q2
$532K Hold
19,607
﹤0.01% 1644
2017
Q1
$444K Sell
19,607
-1,341
-6% -$27.7K ﹤0.01% 1734
2016
Q4
$449K Hold
20,948
﹤0.01% 1809
2016
Q3
$463K Hold
20,948
﹤0.01% 1754
2016
Q2
$374K Hold
20,948
﹤0.01% 1876
2016
Q1
$362K Hold
20,948
﹤0.01% 1790
2015
Q4
$444K Hold
20,948
﹤0.01% 1694
2015
Q3
$395K Hold
20,948
﹤0.01% 1790
2015
Q2
$481K Sell
20,948
-1,471
-7% -$34.3K ﹤0.01% 1780
2015
Q1
$605K Hold
22,419
﹤0.01% 1457
2014
Q4
$648K Hold
22,419
﹤0.01% 1587
2014
Q3
$602K Hold
22,419
﹤0.01% 1599
2014
Q2
$496K Hold
22,419
﹤0.01% 1828
2014
Q1
$612K Hold
22,419
﹤0.01% 1665
2013
Q4
$693K Hold
22,419
﹤0.01% 1582
2013
Q3
$637K Hold
22,419
﹤0.01% 1588
2013
Q2
$572K Buy
+22,419
New +$525K ﹤0.01% 1612

Other funds holding QDEL

Metropolitan Life Insurance Company (MetLife)'s QDEL Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of QuidelOrtho (QDEL) in Q1 2022, closing a stake of 6,762 shares — an estimated $913K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in QDEL in Q2 2013 and held it in 35 quarters. The position peaked at $2.14M in Q2 2020. 354 funds tracked by Wall St. Rank hold QDEL as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining QuidelOrtho position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 6,762 QuidelOrtho shares in Q1 2022, an estimated $913K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in QuidelOrtho in Q2 2013 and held it in 35 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s QuidelOrtho position peaked at $2.14M in Q2 2020.
  • 354 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.